BMJ  2004;328:50 (3 January), doi:10.1136/bmj.328.7430.50

Letter

United Kingdom research governance strategy

Authors' reply

The first 150 words of the full text of this article appear below.

EDITOR—Sullivan is correct that partnerships with industry such as the new networks will need careful scrutiny. Subsequent to the influential Baker report in 1999,1 every government report on research and development and higher education has emphasised the role of industry in NHS research, the most recent being the Bioscience Innovation and Growth Team's report.2

New networks and other bodies have been created to "form a platform to bring in other players from industry and the science base on a collaborative basis to maximise opportunities for innovation and research."3 For example, the National Cancer Research Institute, established to take a strategic oversight of cancer research in the United Kingdom, also has industry represented on its board. The overall policy goals of the institute—namely, the drive to increase subject recruitment to clinical trials and to translate new products more quickly to trials—are consistent across the Pharmaceutical Industry Competitiveness Taskforce, National . . . [Full text of this article]

Susan Kerrison, assistant director, research governance

Nick McNally, assistant director, research and development

nick.mcnally@uclh.org

Allyson M Pollock, director, research and development

University College London Hospitals NHS Trust, London NW1 2LT


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

United Kingdom research governance strategy
Susan Kerrison, Nick McNally, and Allyson M Pollock
BMJ 2003 327: 553-556. [Extract] [Full Text] [PDF]

Access jobs at BMJ Careers
Whats new online at Student BMJ